• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 38 of 100
Gilead coronavirus trial
NewslettersCan Gilead tame the coronavirus?
By Sy MukherjeeFebruary 27, 2020
Gilead remdesivir clinical trials
HealthGilead’s coronavirus treatment is barreling its way into new clinical trials
By Sy MukherjeeFebruary 26, 2020
COVID-19-Coronavirus-microscope
HealthThe first U.S. trial for a coronavirus treatment has started
By Sy MukherjeeFebruary 25, 2020
Japan taps an unexpected drugmaker for its coronavirus treatment
Japan taps an unexpected drugmaker for its coronavirus treatment
By Naomi Xu ElegantFebruary 25, 2020
Antibiotics AI
NewslettersHow A.I. helps sniff out new antibiotics
By Sy MukherjeeFebruary 25, 2020
AUSTRALIA-HEALTH-HOSPITAL-DISEASE-SUPERBUG
HealthScientists are turning to A.I. to discover new antibiotics that can fight superbugs
By Sy MukherjeeFebruary 25, 2020
Sanofi CEO Paul Hudson
NewslettersCoronavirus interruption of drug supply chain pushes Sanofi to open a firm in France
By Sy MukherjeeFebruary 24, 2020
2nd China International Import Expo (CIIE) - Day 2
HealthSanofi is set to launch a new European drug manufacturing firm
By Sy MukherjeeFebruary 24, 2020
China’s high smoking rate may be exacerbating the coronavirus outbreak
HealthChina’s high smoking rate may be exacerbating the coronavirus outbreak
By Sy MukherjeeFebruary 19, 2020
Coronavirus vaccine SARS lessons
HealthSARS treatments could help with the new coronavirus. Why were they shelved?
By Sy MukherjeeFebruary 18, 2020
PSY.03.20.Tim Ferriss-featured image
MagazineBusiness gets ready to trip: How psychedelic drugs may revolutionize mental health care
By Jeffrey M. O'BrienFebruary 17, 2020
AstraZeneca coronavirus
HealthAstraZeneca stock slips on mixed earnings report and coronavirus uncertainty
By Sy MukherjeeFebruary 14, 2020
INV.03.20.Immunotherapy-Drugs
Magazine‘Miracle’ cancer treatments could be a blessing for investors too
By Ryan DerousseauFebruary 13, 2020
generic drug shot gene therapy
CommentaryHow this gene therapy drug earned its $2.1 million price tag
By Sally C. PipesFebruary 7, 2020
CRISPR Gene Editing Trial Cancer Safety
NewslettersFirst step in study shows CRISPR gene-edited cells are safe for use in cancer patients
By Sy MukherjeeFebruary 6, 2020
1...
  • 36
  • 37
  • 38
  • 39
  • 40
...100
Most Popular
Success
Scottie Scheffler joined Tiger Woods and Rory McIlroy in golf's $100M club—and donated his entire Ryder Cup stipend to charityplaceholder alt text
By Fortune EditorsApril 10, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Politics
The Navy confirmed an ‘abundant amount’ of Uncrustables when the Artemis II crew lands. Smucker’s just offered them a lifetime supplyplaceholder alt text
By Fortune EditorsApril 10, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.